ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26)
Recalling firm: ActiPharma, Inc.
Why it was recalled
FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
The exact product
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
Check the codes
Compare these FDA-provided codes, lot numbers or dates with the product you have.
Match the product, size and code together. A similar name alone does not identify your batch.
Original FDA code information
Lot 13309, Exp: 01/26
| Type | Code / value | Context |
|---|---|---|
| UPC | 363102217104 | ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104. |
Recall details
- Recall number
- F-0463-2024
- Event ID
- 93210
- FDA status
- Terminated
- Initiated
- Sep 28, 2023
- Reported
- Nov 29, 2023
- Classified
- Nov 17, 2023
- Terminated
- Jan 16, 2024
- Quantity
- 607 bottles of 100 tablets each
- Location
- Guaynabo, PR, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
Domestic distribution, in Puerto Rico.
FDA source record · F-0463-2024
Data updated September 16, 2026. View official FDA data ↗
A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.